2MH2

Structural insights into the DNA recognition and protein interaction domains reveal fundamental homologous DNA pairing properties of HOP2

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	6 mg/mL [U-99% 13C; U-99% 15N] Hop2, 5% [U-99% 2H] D2O, 10 mM imidazole, 120 mM sodium chloride, 5% glycerol	95% H2O/5% D2O	120	7.8	ambient	293
2	2D 1H-13C HSQC	6 mg/mL [U-99% 13C; U-99% 15N] Hop2, 5% [U-99% 2H] D2O, 10 mM imidazole, 120 mM sodium chloride, 5% glycerol	95% H2O/5% D2O	120	7.8	ambient	293
3	3D CBCA(CO)NH	6 mg/mL [U-99% 13C; U-99% 15N] Hop2, 5% [U-99% 2H] D2O, 10 mM imidazole, 120 mM sodium chloride, 5% glycerol	95% H2O/5% D2O	120	7.8	ambient	293
4	3D C(CO)NH	6 mg/mL [U-99% 13C; U-99% 15N] Hop2, 5% [U-99% 2H] D2O, 10 mM imidazole, 120 mM sodium chloride, 5% glycerol	95% H2O/5% D2O	120	7.8	ambient	293
5	3D HNCO	6 mg/mL [U-99% 13C; U-99% 15N] Hop2, 5% [U-99% 2H] D2O, 10 mM imidazole, 120 mM sodium chloride, 5% glycerol	95% H2O/5% D2O	120	7.8	ambient	293
6	3D HNCA	6 mg/mL [U-99% 13C; U-99% 15N] Hop2, 5% [U-99% 2H] D2O, 10 mM imidazole, 120 mM sodium chloride, 5% glycerol	95% H2O/5% D2O	120	7.8	ambient	293
7	3D HNCACB	6 mg/mL [U-99% 13C; U-99% 15N] Hop2, 5% [U-99% 2H] D2O, 10 mM imidazole, 120 mM sodium chloride, 5% glycerol	95% H2O/5% D2O	120	7.8	ambient	293
8	3D H(CCO)NH	6 mg/mL [U-99% 13C; U-99% 15N] Hop2, 5% [U-99% 2H] D2O, 10 mM imidazole, 120 mM sodium chloride, 5% glycerol	95% H2O/5% D2O	120	7.8	ambient	293
9	3D HCCH-TOCSY	6 mg/mL [U-99% 13C; U-99% 15N] Hop2, 5% [U-99% 2H] D2O, 10 mM imidazole, 120 mM sodium chloride, 5% glycerol	95% H2O/5% D2O	120	7.8	ambient	293
10	3D 1H-15N NOESY	6 mg/mL [U-99% 13C; U-99% 15N] Hop2, 5% [U-99% 2H] D2O, 10 mM imidazole, 120 mM sodium chloride, 5% glycerol	95% H2O/5% D2O	120	7.8	ambient	293
11	3D 1H-15N TOCSY	6 mg/mL [U-99% 13C; U-99% 15N] Hop2, 5% [U-99% 2H] D2O, 10 mM imidazole, 120 mM sodium chloride, 5% glycerol	95% H2O/5% D2O	120	7.8	ambient	293
12	3D HCACO	6 mg/mL [U-99% 13C; U-99% 15N] Hop2, 5% [U-99% 2H] D2O, 10 mM imidazole, 120 mM sodium chloride, 5% glycerol	95% H2O/5% D2O	120	7.8	ambient	293
13	3D HN(CO)CA	6 mg/mL [U-99% 13C; U-99% 15N] Hop2, 5% [U-99% 2H] D2O, 10 mM imidazole, 120 mM sodium chloride, 5% glycerol	95% H2O/5% D2O	120	7.8	ambient	293

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	600

NMR Refinement
Method	Details	Software
distance geometry		NMRPipe

NMR Ensemble Information
Conformer Selection Criteria	back calculated data agree with experimental NOESY spectrum
Conformers Calculated Total Number	40000
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	peak picking	SPARKY		Goddard
3	chemical shift assignment	SPARKY		Goddard
4	chemical shift assignment	PINE		Bahrami, Markley, Assadi, and Eghbalnia
5	data analysis	TALOS		Cornilescu, Delaglio and Bax
6	structure solution	CS-Rosetta		Shen, Vernon, Baker and Bax
7	refinement	RPF		Huang, Powers, Montelione
8	structure validation	Procheck		Laskowski, MacArthur, Smith, Jones, Hutchinson, Morris, Moss and Thornton

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.